# The Health Service Medicines (Information on the Prices of Specified Generic Medicines) Regulations 2001, Regulation 2: Interpretation


(1) In these Regulations—
“group of companies” means a holding company and its subsidiary or, where it has more than one subsidiary, each of them and in this definition “subsidiary” has the same meaning as in section 736(1) of the Companies Act 1985;
“the list of specified generic medicines” means the list of medicines which was published on 20th November 2001 on the internet at http://www.doh.gov.uk/generics/medicines.htm by the Department of Health;
“marketing authorisation” means a marketing authorisation for a medicinal product for human use granted—
(a) by the competent authorities of the United Kingdom in accordance with Council Directive 65/65/EEC of 26th January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products; or
(b) by the European Agency for the Evaluation of Medicinal Products in accordance with Council Regulation (EEC) No. 2309/93 of 22nd July 1993 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products;
“presentation” means a particular form of a medicine which may be distinguished from other forms of that medicine by reference to pack size;
“specified generic health service medicine” means a health service medicine which—
(a) is included in the list of specific generic medicines notwithstanding the addition of a manufacturer’s or supplier’s name or trade mark; but
(b) is not identifiable by and traded under a specified name given to it by any person who is the manufacturer, supplier or holder of a marketing authorisation relating to it;
“supply” means supply by way of sale to a person lawfully conducting a retail pharmacy business or to a registered medical practitioner, in order to enable that person or practitioner (as the case may be) to provide pharmaceutical services within the meaning of—
(a) section 41 of the National Health Service Act 1977 in England or Wales;
(b) section 27 of the National Health Service (Scotland) Act 1978 in Scotland;
(c) article 63 of the Health and Personal Social Services (Northern Ireland) Order 1972 in Northern Ireland.
(2) A health service medicine is supplied on the date on which a contract for its sale for health service use is concluded.
(3) Any reference in these Regulations to a numbered regulation is a reference to a regulation which bears that number in these Regulations and any reference to a numbered paragraph in a regulation is a reference to the paragraph in that regulation which bears that number.

---
Source: https://www.legislation.gov.uk/uksi/2001/3798/regulation/2 (the official version)
Page: https://openlegislation.uk/health-service-medicines-information-on-the-prices-of-specified-generic-medicines-regulations-2001/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

